
Tobacco harm reduction
Tobacco harm reduction
The biggest myth: there isn’t enough evidence


Keeping harm reduction safe

We don’t know if vaping is less harmful than smoking

Second hand vapour is dangerous

Nicotine causes disease

The Royal College of Physicians (RCP)


Vaping is a gateway to smoking

The Canadian Institute for Substance Use Research

Flavours are to attract youth

Vaping’s ineffective for cessation

Controlled clinical trials

Approved cessation methods are effective

Vaping is ineffective for smoking cessation

Dual user isn’t quitting smoking

Listen to the experts
Quotes from those that have done the research

“The most important

“Vapers should

“Saying e-cigs

“People smoke

Dr. Konstantinos Farsalinos
“The most important toxins in cigarette smoke are missing – those that remain are orders of magnitude lower.”

Riccardo Polosa
“Vapres should be more concerned of the air they breathe in polluted cities rather than their vaping!” Dr.

Professor Hajek
Saying e-cigs are 95% safer is not a medical claim, it’s a truth.”

Professor Michael Russell, 1976
“People smoke for nicotine but they die from the tar.”
50. Polosa, R., Rodu, B., Caponnetto, P., Maglia, M., & Raciti, C. (2013). A fresh look at tobacco harm reduction: the case for the electronic cigarette.
51. Canadian Nurses Association. (2017). Code of ethics for registered nurses.
52. Nutt, D. J., Phillips, L. D., Balfour, D., Curran, H. V., Dockrell, M., Foulds, J., Fagerstrom, K., Letlape, K., Milton, A., Polosa, R., Ramsey, J., & Sweanor, D. (2014). Estimating the harms of nicotine-containing products using the MCDA approach.
53. Burstyn, I. (2014). Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks.
54. Filipiak, W., Ruzsanyi, V., Mochalski, P., Filipiak, A., Bajtarevic, A., Ager1, C., Denz1, H., Hilbe W., Jamnig, H., Hackl, M., Dzien, A., & Amann, A. (2012). Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants.
55. Laugesen, M. (2013). Nicotine and health. New York, NY: American Council on Science and Health.
56. Royal Society for Public Health. (2015). Nicotine “no more harmful than caffeine”.
57. Royal College of Physicians. (2016). Nicotine without smoke: Tobacco harm reduction: A report by the Tobacco Advisory Group of the Royal College of Physicians.
58. Government of Canada. (2015). Canadian Student Tobacco, Alcohol and Drugs Survey.
59. Jackson, C. A., Henderson, M., Frank, J. W., Haw, S. J. (2012). An overview of prevention of multiple risk behaviour in adolescence and young adulthood.
60. Government of Canada. (2019). Canadian Student Tobacco, Alcohol and Drugs Survey.
61. O’Leary, R., MacDonald, M., Stockwell, T., & Reist, D. (2017). Clearing the Air: A systematic review on the harms and benefits of e-cigarettes and vapour devices. Victoria, BC: Centre for Addictions Research of BC.
62. University of Victoria: UVic News. (2107). Clearing the air around e-cigarettes. Retrieved Feb. 19, 2020 from https://www.uvic.ca/news/topics/2017+e-cigarettes-carbc-macdonald-stockwell+media-release
63. Statistics Canada. (2017). Canadian Health Measures Survey.
64. Aslani, A., & Rafiei, S. (2012). Design, formulation and evaluation of nicotine chewing gum.
65. Russell, C., McKeganey, N., Dickson, T., & Nides, M. (2018). Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USA.
66. Government of Canada. (2019). The risks of vaping.
67. Institute of Economic Affairs. (2013). Free market solutions in health: The case of nicotine.
68. Government of Canada. (2017) Canadian Tobacco, Alcohol and Drugs Survey (CTADS).
69. Farsalinos, K., Polosa, R., Cibella, C., & Niaura, R. (2019). Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys.
70. Adriaens, K., Van Gucht, D., Declerck, P., & Baeyens, F. (2014). Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints.
71. Nides, M., Leischow, S.J., Bhatter, M., & Simmons, M. (2014). Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system.
72. Polosa, R., Rodu, B., Caponnetto, P., Maglia, M., & Raciti, C. (2013). A fresh look at tobacco harm reduction: the case for the electronic cigarette.
73. Shahab, L., Brose, L.S., & West R. (2013). Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: Rationale, and evidence for advantages over existing systems.
74. Polosa, R., Rodu, B., Caponnetto, P., Maglia, M., & Raciti, C. (2013). A fresh look at tobacco harm reduction: the case for the electronic cigarette.
75. Institute for Safe Medication Practices. (2008). QuarterWatch Report: Strong Safety Signal Seen for Chantix (Varenicline).
76. Dawkins, L. (2013). Why is it so hard to quit smoking?
77. Farsalinos, K., Spyrou, A., Tsimopoulou, K. et al. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices.
78. Farsalinos, K., Spyrou, A., Stefopoulos, C. et al. Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers).